Table 3: Clinical outcome during follow-up.

Patient The Period from Onset to Renal Biopsy (months) Treatment The period from Treatment Initiation to Remission (months) Renal Dysfunction Follow-up After Treatment Initiation (months)
1 3 ACE-I 5 - 66
2 1 PSL 2 - 37
3 NA PSL, ACE-I, ARB 16 - 75
4 2 PSL 19 - 106
5 1 PSL 8 - 138
6 1 PSL 5 - 50
7 2 ACE-I 13 - 40
8 2 ACE-I 9 - 33
9 9 ACE-I 5 - 11
10 7 ACE-I no remission - 7
11 3 ACE-I no remission - 11

PSL: prednisolone, ACE-I: angiotensin converting enzyme inhibitor, ARB: angiotensin II receptor blocker, NA: data not available

Back to Article